Scarica l'app Stockscreener
0.9152
4.37%
0.0383
Dopo l'orario di chiusura:
.92
0.0048
+0.52%
Precedente Chiudi:
$0.8769
Aprire:
$0.86
Volume 24 ore:
150.29K
Relative Volume:
0.55
Capitalizzazione di mercato:
$29.77M
Reddito:
$950.10K
Utile/perdita netta:
$-16.69M
Rapporto P/E:
-1.1027
EPS:
-0.83
Flusso di cassa netto:
$-15.16M
1 W Prestazione:
-2.31%
1M Prestazione:
+3.41%
6M Prestazione:
-20.42%
1 anno Prestazione:
-21.10%
Intervallo 1D:
$0.86
$0.9252
Intervallo di 1 settimana:
$0.86
$0.94
Portata 52W:
$0.693
$1.80
Femasys Inc Stock (FEMY) Company Profile
Nome
Femasys Inc
Settore
Industria
Telefono
770-500-3910
Indirizzo
3950 JOHNS CREEK COURT, SUWANEE
Confronta FEMY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.9152 | 28.47M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
488.61 | 179.91B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
183.63 | 52.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.90 | 45.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.50 | 40.08B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
279.10 | 16.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Femasys Inc Borsa (FEMY) Ultime notizie
Will Femasys Inc. stock benefit from AI tech trendsHigh-return market picks - jammulinksnews.com
What drives Femasys Inc. stock pricePowerful profit generation - Autocar Professional
Femasys Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
What analysts say about Femasys Inc. stockExponential return rates - jammulinksnews.com
Is Femasys Inc. a good long term investmentLightning-fast growth - Autocar Professional
Femasys Faces Nasdaq Noncompliance Notice: Stock Price Below $1.00 for 30 Consecutive Business Days - AInvest
Femasys Faces Nasdaq Noncompliance Notice for Stock Price - TipRanks
Femasys receives Nasdaq notice for minimum bid price noncompliance - Investing.com Australia
Femasys receives Nasdaq notice for minimum bid price noncompliance By Investing.com - Investing.com Nigeria
Why Femasys Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser
How Femasys Inc. stock performs during market volatilityShort Term Profit Focus - Newser
What makes Femasys Inc. stock price move sharplyVolume Spike Monitors - Newser
Femasys Enters Purchase Agreement with Alumni Capital - MSN
Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Gets Australia, New Zealand Approvals for Two Products - MarketScreener
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
Femasys Inc Azioni (FEMY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):